Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. 22 Nov Dr D Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Cannabinoids inhibit cellular respiration of human oral cancer cells.